technology
Why Quest Diagnostics Holdings Stock Dropped Today
Medical testing giant Quest Diagnostics (NYSE: DGX) stock slipped 5.1% through 11:30 a.m. Tuesday, after the Centers for Medicare & Medicaid Services (CMS) disclosed Monday that they've been paying about 16% more for lab work than private insurers pay. No longer. Effective Jan. 1, 2027, CMS says...
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Google Releases New Gemini Model With Guardrails Amid A.I. Safety Debate
NYT Technology
F.T.C. Investigates OpenAI and Anthropic Over Potential Consumer Harms
NYT Technology
Capcom Knows Its Resident Evil Remakes Will Eventually Catch Up With Newer Games, But Has a Plan For When That Happens
IGN
You can now play the original Halo in your browser, 128-player multiplayer included
TechSpot
Everything We've Learned
IGN